JMP Securities Reiterates Market Outperform Rating on Marinus Pharmaceuticals (MRNS) Aug 13, 2024 04:09PM
Marinus Pharmaceuticals (MRNS) PT Lowered to $22 at JMP Securities, Following Clinical Business Update Feb 3, 2022 03:10PM
Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences Jun 11, 2021 07:30AM
Marinus Pharmaceuticals to Participate at Upcoming Investor Conferences Jun 3, 2019 07:30AM
Marinus Pharmaceuticals (MRNS ) PT Lowered to $21 at JMP Securities Mar 12, 2019 02:12AM


Dec 10, 2018 11:40AM Marinus Pharmaceuticals (MRNS) PT Raised to $29 at JMP Securities
May 30, 2018 07:30AM Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 19, 2017 04:01PM Marinus Pharmaceuticals Announces closing of Public Offering of Common Stock and full exercise of underwriter’s option to purchase additional shares
Sep 15, 2017 07:31AM Marinus Pharma (MRNS) Prices 9.33M Common Stock Offering at $3.75/Share
Sep 15, 2017 07:30AM Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Sep 14, 2017 04:02PM Marinus Pharmaceuticals (MRNS) to Offer Common Stock
Sep 14, 2017 04:01PM Marinus Pharmaceuticals Announces Public Offering of Common Stock
Sep 12, 2017 04:15AM Marinus Pharmaceuticals (MRNS) PT Raised to $11 at JMP Securities, Positvely Revises EPS Estimate
Sep 11, 2017 05:50PM Marinus Pharmaceuticals (MRNS) PT Raised to $11 at JMP Securities
Nov 6, 2015 09:15AM Marinus Pharma (MRNS) 5M Common Stock Offering Prices at $6/Share
Nov 6, 2015 09:08AM Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jun 16, 2015 07:30AM Marinus Pharmaceuticals to Present at JMP Securities Life Sciences Conference
Sep 2, 2014 07:00AM Marinus Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
Aug 26, 2014 08:23AM JMP Securities Starts Marinus Pharmaceuticals (MRNS) at Market Outperform
Jul 31, 2014 12:06PM Marinus Pharmaceuticals (MRNS) IPO Opens Flat
Jul 31, 2014 09:27AM Marinus Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering